Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -28.72% is 22% above its 5-year average of -36.82%, near the high end of its 5-year range (-51.16%–-22.02%).
As of the fiscal period ended Tuesday, June 30, 2026. 25.76% above its 12-month average of -38.69%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q3 FY2026 (2026-06-30): -28.72%.
RETURN ON INVESTED CAPITAL (ROIC)
-28.72%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-38.69%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-36.41%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-36.82%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+25.76%
CURRENT VS 3Y AVG
+21.11%
CURRENT VS 5Y AVG
+22.00%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.66%
median of 837 covered companies
CURRENT VS SECTOR MEDIAN
+19.45%
vs the sector median at left
Optimi Health Corp.
Market Cap
$13.30M
Return on Invested Capital (ROIC)
-28.72%
TTM Avg
-38.69%
3Y Avg
-36.41%
5Y Avg
-36.82%
Market Cap
$13.33M
Return on Invested Capital (ROIC)
-91.74%
TTM Avg
-119.31%
3Y Avg
-112.64%
5Y Avg
-88.90%
Market Cap
$13.20M
Return on Invested Capital (ROIC)
-67.62%
TTM Avg
-48.11%
3Y Avg
-41.05%
5Y Avg
-37.60%
Market Cap
$13.11M
Return on Invested Capital (ROIC)
-889.92%
TTM Avg
-97.42%
3Y Avg
-82.73%
5Y Avg
-70.79%
Market Cap
$13.75M
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.78M
Return on Invested Capital (ROIC)
-86.22%
TTM Avg
-227.24%
3Y Avg
-220.51%
5Y Avg
-220.51%
Market Cap
$13.86M
Return on Invested Capital (ROIC)
-157.90%
TTM Avg
-186.85%
3Y Avg
-152.06%
5Y Avg
-115.52%
Market Cap
$12.58M
Return on Invested Capital (ROIC)
-784.16%
TTM Avg
-160.08%
3Y Avg
-118.03%
5Y Avg
-103.52%
Market Cap
$14.05M
Return on Invested Capital (ROIC)
-13.15%
TTM Avg
-23.00%
3Y Avg
-25.06%
5Y Avg
-54.51%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Optimi Health Corp. (OPTH) | $13.30M | -28.72% | -38.69% | -36.41% | -36.82% |
| IN8bio, Inc. (INAB)vs › | $13.33M | -91.74% | -119.31% | -112.64% | -88.90% |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $13.20M | -67.62% | -48.11% | -41.05% | -37.60% |
| Passage Bio, Inc. (PASG)vs › | $13.11M | -889.92% | -97.42% | -82.73% | -70.79% |
| Obsidian Therapeutics Inc. (OBX)vs › | $13.75M | N/A | N/A | N/A | N/A |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $12.78M | -86.22% | -227.24% | -220.51% | -220.51% |
| Sintx Technologies, Inc. (SINT)vs › | $13.86M | -157.90% | -186.85% | -152.06% | -115.52% |
| Tempest Therapeutics, Inc. (TPST)vs › | $12.58M | -784.16% | -160.08% | -118.03% | -103.52% |
| Pulsenmore Ltd. Ordinary Shares (PLSM)vs › | $14.05M | -13.15% | -23.00% | -25.06% | -54.51% |
| Dare Bioscience, Inc. (DARE)vs › | $12.48M | -203.50% | -154.20% | -205.70% | -169.89% |
ROIC
-28.7%
ROE
-39.8%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -28.72% |
| 2026-03-31 | -50.93% |
| 2025-12-31 | -40.44% |
| 2025-09-30 | -34.92% |
| 2025-06-30 | -38.45% |
| 2025-03-31 | -43.17% |
| 2024-12-31 | -47.28% |
| 2024-09-30 | -41.98% |
| 2024-06-30 | -36.93% |
| 2024-03-31 | -37.03% |
| 2023-12-31 | -25.24% |
| 2023-09-30 | -23.40% |
| 2023-06-30 | -24.86% |
| 2023-03-31 | -22.02% |
| 2022-12-31 | -31.40% |
| 2022-09-30 | -45.64% |
| 2022-06-30 | -46.52% |
| 2022-03-31 | -51.16% |
| 2021-12-31 | -41.18% |
| 2021-09-30 | -25.22% |
